Related references
Note: Only part of the references are listed.A new isoquinolone alkaloid from an endophytic fungus R22 of Nerium indicum
Yang-min Ma et al.
NATURAL PRODUCT RESEARCH (2017)
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
Vanessa W. Stevens et al.
JAMA INTERNAL MEDICINE (2017)
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
Maureen Watt et al.
JOURNAL OF MEDICAL ECONOMICS (2017)
Hiding in Plain Sight: Mining Bacterial Species Records for Phenotypic Trait Information
Albert Barberan et al.
MSPHERE (2017)
Inhibition of spore germination, growth, and toxin activity of clinically relevant C-difficile strains by gut microbiota derived secondary bile acids
Rajani Thanissery et al.
ANAEROBE (2017)
Probiotics and prevention of Clostridium difficile infection
E. J. C. Goldstein et al.
ANAEROBE (2017)
Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor
Disha Bhattacharjee et al.
JOURNAL OF BACTERIOLOGY (2016)
Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys
William Walters et al.
MSYSTEMS (2016)
Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study
William Sangster et al.
FRONTIERS IN MICROBIOLOGY (2016)
VSEARCH: a versatile open source tool for metagenomics
Torbjorn Rognes et al.
PEERJ (2016)
Interspecies Interactions between Clostridium difficile and Candida albicans
Pim T. van Leeuwen et al.
MSPHERE (2016)
The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain
Keshan Zhang et al.
ANAEROBE (2015)
Comparative Microbiological Studies of Transcription Inhibitors Fidaxomicin and the Rifamycins in Clostridium difficile
Farah Babakhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers
Heba S. Said et al.
DNA RESEARCH (2014)
Clostridium difficile and the microbiota
Anna M. Seekatz et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Sequence Depth, Not PCR Replication, Improves Ecological Inference from Next Generation DNA Sequencing
Dylan P. Smith et al.
PLOS ONE (2014)
Lavage with Allicin in Combination with Vancomycin Inhibits Biofilm Formation by Staphylococcus epidermidis in a Rabbit Model of Prosthetic Joint Infection
Haohan Zhai et al.
PLOS ONE (2014)
Recurrent Clostridium difficile infections: The importance of the intestinal microbiota
Marie Celine Zanella Terrier et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Casey M. Theriot et al.
NATURE COMMUNICATIONS (2014)
Effects of Antibiotics on Bacterial Species Composition and Metabolic Activities in Chemostats Containing Defined Populations of Human Gut Microorganisms
Dorothy F. Newton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Novel isoquinoline derivatives as antimicrobial agents
Abraham Galan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen
Lorenza Tulli et al.
CELLULAR MICROBIOLOGY (2013)
Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
Vijay C. Antharam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection
S. N. Bass et al.
JOURNAL OF HOSPITAL INFECTION (2013)
Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization
Patrizia Spigaglia et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Towards a unified paradigm for sequence-based identification of fungi
Urmas Koljalg et al.
MOLECULAR ECOLOGY (2013)
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Katharine M. Ng et al.
NATURE (2013)
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Morgan G. I. Langille et al.
NATURE BIOTECHNOLOGY (2013)
Differential abundance analysis for microbial marker-gene surveys
Joseph N. Paulson et al.
NATURE METHODS (2013)
Fidaxomicin for the Treatment of Clostridium difficile infections
Craig B. Whitman et al.
ANNALS OF PHARMACOTHERAPY (2012)
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Antimicrobial Activities of Fidaxomicin
Ellie J. C. Goldstein et al.
CLINICAL INFECTIOUS DISEASES (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
How glycan metabolism shapes the human gut microbiota
Nicole M. Koropatkin et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Microbial Co-occurrence Relationships in the Human Microbiome
Karoline Faust et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile
Farah Babakhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
Kathleen M. Mullane et al.
CLINICAL INFECTIOUS DISEASES (2011)
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Vanessa Stevens et al.
CLINICAL INFECTIOUS DISEASES (2011)
Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy
C. Elsing et al.
INFECTION (2011)
Role of fibronectin-binding protein A in Clostridium difficile intestinal colonization
Amira Barketi-Klai et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
In Vitro Activity of Fidaxomicin (OPT-80) Tested against Contemporary Clinical Isolates of Staphylococcus spp. and Enterococcus spp.
Douglas J. Biedenbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Search and clustering orders of magnitude faster than BLAST
Robert C. Edgar
BIOINFORMATICS (2010)
QIIME allows analysis of high-throughput community sequencing data
J. Gregory Caporaso et al.
NATURE METHODS (2010)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Prevention of Clostridium difficile infection with Saccharomyces boulardii: A systematic review
Jennifer M. Tung et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3
Samir Jawhara et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB
T. Z. DeSantis et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Share Paper
